In this Review, Tentler et al. present the opportunities and challenges of using patient-derived tumour xenograft models in oncology drug development, provide specific disease examples, and describe concepts regarding predictive biomarker development and future applications.
- John J. Tentler
- Aik Choon Tan
- S. Gail Eckhardt